V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014146 | 160012500 | 1.52 | 65 | Palliative (P) | 2020-08-24 | 2020-09-12 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101460595 |
| 160014149 | 160012501 | 1.83 | 64.1 | null | 2018-05-27 | 2018-06-20 | Bevacizumab 7.5mg/kg | 02 | null | PACLITAXEL | 101725139 |
| 160014152 | 160012502 | 1.69 | 63.3 | null | 2019-01-30 | 2019-02-19 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100314723 |
| 160014156 | 160012503 | 1.81 | 74 | Adjuvant (A) | 2019-09-17 | 2019-09-26 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101788832 |
| 160014164 | 160012504 | 1.52 | 64.7 | null | 2015-01-07 | 2015-01-27 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100651428 |
| 160014165 | 160012505 | 1.72 | 46 | Palliative (P) | 2017-10-26 | 2017-10-27 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 100084199 |
| 160014167 | 160012506 | 1.57 | 49.7 | null | 2020-02-29 | 2020-04-11 | Bevacizumab | 02 | null | LIPOSOMAL DOXORUBICIN | 100176565 |
| 160014171 | 160012507 | 1.7 | 65.8 | Palliative (P) | 2019-01-01 | 2019-01-02 | Bevacizumab 7.5mg/kg | N | N | DOCETAXEL + GEMCITABINE | 101021221 |
| 160014172 | 160012508 | 1.7 | 96.7 | Palliative (P) | 2021-12-15 | 2022-01-02 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100479425 |
| 160014174 | 160012509 | 1.65 | 86.8 | Palliative (P) | 2016-06-04 | 2016-06-11 | Bevacizumab 7.5mg/kg | 2 | N | DOXORUBICIN + OLARATUMAB | 101034093 |
| 160014182 | 160012510 | 1.7 | 73 | Neo-adjuvant (N) | 2020-09-17 | 2020-09-30 | Bevacizumab | 02 | N | PACLITAXEL | 101144946 |
| 160014186 | 160012511 | 1.48 | 79 | null | 2018-01-05 | 2018-01-24 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101753059 |
| 160014196 | 160012512 | 1.51 | 74.9 | Palliative (P) | 2018-05-24 | 2018-12-06 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101630269 |
| 160014199 | 160012513 | 1.6 | 68.5 | Palliative (P) | 2020-06-23 | 2020-08-11 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101381247 |
| 160014201 | 160012514 | 1.71 | 122.2 | Palliative (P) | 2019-10-26 | 2019-10-28 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100414099 |
| 160014209 | 160012515 | 1.71 | 75 | null | null | null | Bevacizumab 7.5mg/kg | null | null | BEVACIZUMAB | 101336868 |
| 160014212 | 160012516 | 1.52 | 52.7 | Palliative (P) | 2017-10-29 | 2017-11-12 | Bevacizumab | 02 | N | PACLITAXEL | 100568521 |
| 160014217 | 160012517 | 1.46 | 69 | Palliative (P) | 2018-02-12 | 2018-02-12 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101109654 |
| 160014218 | 160012518 | 156 | 73.85 | Palliative (P) | 2020-12-18 | 2020-12-18 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100231245 |
| 160014221 | 160012519 | 1.74 | 65.2 | Palliative (P) | 2018-02-04 | 2018-02-11 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101604793 |
| 160014224 | 160012520 | 1.67 | 79.9 | Palliative (P) | 2018-08-18 | 2018-11-19 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101212554 |
| 160014225 | 160012521 | 1.74 | 63.7 | 03 | 2019-07-31 | 2019-08-14 | Bevacizumab 7.5mg/kg | N | N | BEVACIZUMAB | 101291401 |
| 160014226 | 160012522 | 1.73 | 83 | Palliative (P) | 2020-03-29 | 2020-04-07 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN | 101533771 |
| 160014227 | 160012523 | 1.83 | 46.3 | Palliative (P) | 2019-06-18 | 2019-07-09 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 101656471 |
| 160014230 | 160012524 | 1.73 | 70 | null | 2018-04-25 | 2018-04-30 | Bevacizumab | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100654567 |
| 160014231 | 160012525 | 1.39 | 77.2 | Neo-adjuvant (N) | 2020-06-11 | 2020-06-11 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 101452073 |
| 160014232 | 160012526 | 1.77 | 83 | null | 2019-08-17 | 2019-08-31 | Carboplatin AUC 6 - 10 | 2 | null | CARBOPLATIN | 101221741 |
| 160014236 | 160012527 | 1.78 | 60 | Palliative (P) | null | 2016-08-11 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100196389 |
| 160014238 | 160012528 | 1.5 | 60.6 | Adjuvant (A) | 2016-08-10 | 2016-08-30 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 101546371 |
| 160014239 | 160012529 | 1.78 | 92.6 | Palliative (P) | 2018-11-26 | 2018-11-29 | PACLITAXEL | 02 | N | PACLITAXEL | 100669593 |
| 160014240 | 160012530 | 1.64 | 52.1 | Palliative (P) | 2017-04-28 | 2017-05-12 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101075444 |
| 160014241 | 160012531 | 1.66 | 59.75 | Palliative (P) | 2016-11-26 | 2016-12-02 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101557974 |
| 160014243 | 160012532 | 1.81 | 89 | Palliative (P) | 2018-06-01 | 2018-06-01 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100035126 |
| 160014246 | 160012533 | 1.7 | 88.15 | Palliative (P) | 2016-10-19 | 2016-11-11 | DOCETAXEL + GEMCITABINE | N | N | DOCETAXEL + GEMCITABINE | 101528673 |
| 160014249 | 160012534 | 1.66 | 58 | null | 2020-02-24 | 2020-03-23 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + GEMCITABINE | 100034993 |
| 160014250 | 160012535 | 1.54 | 60.7 | Palliative (P) | 2018-06-05 | 2019-10-20 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101556141 |
| 160014251 | 160012536 | 0 | 64.1 | Palliative (P) | 2018-08-02 | 2018-08-10 | Bevacizumab 7.5mg/kg | N | N | DOCETAXEL + GEMCITABINE | 100231425 |
| 160014252 | 160012537 | 1.55 | 48 | 03 | 2019-09-19 | 2019-10-03 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101626147 |
| 160014253 | 160012538 | 1.92 | 75.7 | Disease modification (D) | 2016-01-08 | 2016-02-22 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100045106 |
| 160014255 | 160012539 | 1.51 | 88.6 | null | 2020-05-15 | 2020-05-17 | Bevacizumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100927878 |
| 160014257 | 160012540 | 1.51 | 58 | Palliative (P) | 2019-07-16 | 2019-07-16 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100968852 |
| 160014258 | 160012541 | 1.67 | 94 | Neo-adjuvant (N) | 2021-03-27 | 2021-04-17 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100245727 |
| 160014259 | 160012542 | 1.63 | 68.6 | Adjuvant (A) | 2016-06-03 | 2016-06-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100220624 |
| 160014260 | 160012543 | 1.71 | 64.2 | Palliative (P) | 2019-08-28 | 2020-03-19 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101338387 |
| 160014265 | 160012544 | null | 59.6 | null | 2020-02-26 | 2020-03-09 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101288697 |
| 160014267 | 160012545 | 1.73 | 82.2 | null | 2019-08-01 | 2019-08-22 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 101022381 |
| 160014271 | 160012546 | 1.84 | 92 | Neo-adjuvant (N) | 2019-01-08 | 2019-01-08 | Bevacizumab 15mg/kg | 02 | null | PACLITAXEL | 100692512 |
| 160014272 | 160012547 | 1.66 | 79.1 | Adjuvant (A) | 2015-04-24 | 2016-08-24 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100808748 |
| 160014273 | 160012548 | 1.73 | 66.2 | Palliative (P) | 2019-05-02 | 2019-05-08 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100163611 |
| 160014274 | 160012549 | 1.62 | 57 | Palliative (P) | 2018-04-16 | 2018-05-04 | Docetaxel + Gemcitabine with GCSF | 02 | null | DOCETAXEL + GEMCITABINE | 101194090 |